Synthesis of multilayered alginate microcapsules for the sustained release of fibroblast growth factor-1

Journal of Biomedical Materials Research - Part A

Volumn 95 A, Issue 2, 2010, Pages 632-640

  Khanna, Omaditya ^a   Moya, Monica L ^a,b   Opara, Emmanuel C ^a,b,c   Brey, Eric M ^a,b,d  

^a Illinois Institute of Technology   (United States)

^b ILLINOIS INSTITUTE OF TECHNOLOGY   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d HINES VA HOSPITAL   (United States)

Author keywords

alginate; angiogenesis; encapsulation; FGF 1; neovascularization

Indexed keywords

ALGINATE LAYER; ALGINATE MICROCAPSULES; ANGIOGENESIS; ANGIOGENIC FACTOR; BIOLOGIC ACTIVITIES; ENCAPSULATED CELL; ENCAPSULATION SYSTEMS; FGF-1; FIBROBLAST GROWTH FACTOR-1; GULURONIC ACID; MANNURONIC ACIDS; MASS TRANSPORT; MICROVASCULAR NETWORK; MULTI-LAYERED; NEOVASCULARIZATION; OUTER LAYER; PERMSELECTIVITIES; POLY L ORNITHINES; PROTEIN ENCAPSULATION; RELEASE KINETICS; SUSTAINED RELEASE; THERAPEUTIC POTENTIALS; TYPE 1 DIABETES;

ACIDS; AMINO ACIDS; CELL CULTURE; ENCAPSULATION; FIBROBLASTS; PEPTIDES;

ALGINATE;

ALGINIC ACID; FIBROBLAST GROWTH FACTOR 1; HEPARIN; MANNURONIC ACID;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENCAPSULATION; MICROCAPSULE;

ALGINATES; ANGIOGENIC PROTEINS; ANIMALS; CAPSULES; DELAYED-ACTION PREPARATIONS; FIBROBLAST GROWTH FACTOR 1; GLUCURONIC ACID; HEXURONIC ACIDS; MATERIALS TESTING; PARTICLE SIZE;

EID: 78149346746     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32883     Document Type: Article

References (39)

1. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV,. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-238.
2. Menger MD, Messmer K,. Pancreatic islet transplantation: Isolation, separation, and microvascularization. Wien Klin Wochenschr 1992; 104: 429-433.
3. Avila JG, Wang Y, Barbaro B, Gangemi A, Qi M, Kuechle J, Doubleday N, Doubleday M, Churchill T, Salehi P, Shapiro J, Phillipson LH, Benedetti E, Lakey JR, Oberholzer J,. Improved outcomes in islet isolation and transplantation by the use of a novel hemoglobin-based O2 carrier. Am J Transplant 2006; 6: 2861-2870.
4. Opara EC, Kendall WF Jr,. Immunoisolation techniques for islet cell transplantation. Expert Opin Biol Ther 2002; 2: 503-511.
5. Beck J, Angus R, Madsen B, Britt D, Vernon B, Nguyen KT,. Islet encapsulation: Strategies to enhance islet cell functions. Tissue Eng 2007; 13: 589-599.
6. Davalli AM, Scaglia L, Zangen DH, Hollister J, Bonner-Weir S, Weir GC,. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 1996; 45: 1161-1167.
7. Dionne KE, Colton CK, Yarmush ML,. Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans. Diabetes 1993; 42: 12-21.
8. Suzuki R, Okada N, Miyamoto H, Yoshioka T, Sakamoto K, Oka H, Tsutsumi Y, Nakagawa S, Miyazaki J, Mayumi T,. Cyotomedical therapy for insulinopenic diabetes using microencapsulated pancreatic beta cell lines. Life Sci 2002; 71: 1717-1729.
9. Stabler C, Wilks K, Sambanis A, Constantinidis I,. The effects of alginate composition on encapsulated betaTC3 cells. Biomaterials 2001; 22: 1301-1310.
10. Gombotz WR, Wee SF,. Protein release from alginate matrices. Adv Drug Deliv Rev 1998; 31: 267-285.
11. Takka S, Acarturk F,. Calcium alginate microparticles for oral administration: I: Effect of sodium alginate type on drug release and drug entrapment efficiency. J Microencapsul 1999; 16: 275-290. (Pubitemid 29191812)
12. Moya ML, Garfinkel MR, Liu X, Lucas S, Opara EC, Greisler HP, Brey EM,. Fibroblast growth factor-1 (FGF-1) loaded microbeads enhance local capillary neovascularization. J Surg Res 2010; 160: 208-212.
13. Kizilel S, Garfinkel M, Opara E,. The bioartificial pancreas: Progress and challenges. Diabetes Technol Ther 2005; 7: 968-985.
14. De Vos P, De Haan BJ, Wolters GH, Strubbe JH, Van Schilfgaarde R,. Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets. Diabetologia 1997; 40: 262-270.
15. Rivas-Carrillo JD, Navarro-Alvarez N, Soto-Gutierrez A, Okitsu T, Chen Y, Tabata Y, Misawa H, Noguchi H, Matsumoto S, Tanaka N, Kobayashi N,. Amelioration of diabetes in mice after single-donor islet transplantation using the controlled release of gelatinized FGF-2. Cell Transplant 2006; 15: 939-944.
16. Lai Y, Schneider D, Kidszun A, Hauck-Schmalenberger I, Breier G, Brandhorst D, Brandhorst H, Iken M, Brendel MD, Bretzel RG, Linn T,. Vascular endothelial growth factor increases functional beta-cell mass by improvement of angiogenesis of isolated human and murine pancreatic islets. Transplantation 2005; 79: 1530-1536.
17. Becerril C, Pardo A, Montano M, Ramos C, Ramirez R, Selman M,. Acidic fibroblast growth factor induces an antifibrogenic phenotype in human lung fibroblasts. Am J Respir Cell Mol Biol 1999; 20: 1020-1027.
18. Ding I, Wu T, Matsubara H, Magae J, Shou M, Cook J, Okunieff P,. Acidic fibroblast growth factor (FGF1) increases survival and haematopoietic recovery in total body irradiated C3H/HeNCr mice. Cytokine 1997; 9: 59-65.
19. Uriel S, Brey EM, Greisler HP,. Sustained low levels of fibroblast growth factor-1 promote persistent microvascular network formation. Am J Surg 2006; 192: 604-609.
20. Moya ML, Lucas S, Francis-Sedlak M, Liu X, Garfinkel MR, Huang JJ, Cheng MH, Opara EC, Brey EM,. Sustained delivery of FGF-1 increases vascular density in comparison to bolus administration. Microvasc Res 2009; 78: 142-147.
21. Moya ML, Cheng MH, Huang JJ, Francis-Sedlak ME, Kao SW, Opara EC, Brey EM,. The effect of FGF-1 loaded alginate microbeads on neovascularization and adipogenesis in a vascular pedicle model of adipose tissue engineering. Biomaterials 2010; 31: 2816-2826.
22. Garfinkel MR, Harland RC, Opara EC,. Optimization of the microencapsulated islet for transplantation. J Surg Res 1998; 76: 7-10.
23. Darrabie MD, Kendall WF Jr, Opara EC,. Characteristics of Poly-L-Ornithine-coated alginate microcapsules. Biomaterials 2005; 26: 6846-6852.
24. Yamagiwa K, Kozawa T, Ohkawa A,. Effects of alginate composition and gelling conditions on diffusional and mechanical properties of calcium-alginate gel beads. J Chem Eng Jpn 1995; 28: 462-467.
25. Klokk TI, Melvik JE,. Controlling the size of alginate gel beads by use of a high electrostatic potential. J Microencapsul 2002; 19: 415-424.
26. Becker TA, Kipke DR, Brandon T,. Calcium alginate gel: A biocompatible and mechanical stable polymer for endovascular embolization. J Biomed Mater Res 2000; 54: 76-86.
27. Draget KI, Stokke BT, Yuguchi Y, Urakawa H, Kajiwara K,. Small-angle X-ray scattering and rheological characterization of alginate gels. 3. Alginic acid gels. Biomacromolecules 2003; 4: 1661-1668.
28. 2+ ions. React Funct Polym 2004; 59: 129-140.
29. Moya ML,. Optimizing alginate microbead delivery system for release of angiogenic protein for neovascularization. PhD Thesis. Chicago: Illinois Institute of Technology; 2009. p 119.
30. Kilkenny DM, Rocheleau JV,. Fibroblast growth factor receptor-1 signaling in pancreatic islet beta-cells is modulated by the extracellular matrix. Mol Endocrinol 2008; 22: 196-205.
31. Amsden B, Turner N,. Diffusion characteristics of calcium alginate gels. Biotechnol Bioeng 1999; 65: 605-610.
32. Sakiyama-Elbert SE, Hubbell JA,. Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix. J Control Release 2000; 69: 149-158.
33. Sakiyama SE, Schense JC, Hubbell JA,. Incorporation of heparin-binding peptides into fibrin gels enhances neurite extension: An example of designer matrices in tissue engineering. FASEB J 1999; 13: 2214-2224.
34. Sakiyama-Elbert SE, Hubbell JA,. Development of fibrin derivatives for controlled release of heparin-binding growth factors. J Control Release 2000; 65: 389-402.
35. Kang SS, Gosselin C, Ren D, Greisler HP,. Selective stimulation of endothelial cell proliferation with inhibition of smooth muscle cell proliferation by fibroblast growth factor-1 plus heparin delivered from fibrin glue suspensions. Surgery 1995; 118: 280-286; discussion 286-287.
36. Pineda-Lucena A, Jimenez MA, Lozano RM, Nieto JL, Santoro J, Rico M, Gimenez-Gallego G,. Three-dimensional structure of acidic fibroblast growth factor in solution: Effects of binding to a heparin functional analog. J Mol Biol 1996; 264: 162-178.
37. Lopez JJ, Edelman ER, Stamler A, Hibberd MG, Prasad P, Thomas KA, DiSalvo J, Caputo RP, Carrozza JP, Douglas PS, Sellke FW, Simons M,. Angiogenic potential of perivascularly delivered aFGF in a porcine model of chronic myocardial ischemia. Am J Physiol 1998; 274 (3 pt 2): H930-H936.
38. Xue L, Tassiopoulos AK, Woloson SK, Stanton DL Jr, Ms CS, Hampton B, Burgess WH, Greisler HP,. Construction and biological characterization of an HB-GAM/FGF-1 chimera for vascular tissue engineering. J Vasc Surg 2001; 33: 554-560.
39. Brewster LP, Brey EM, Tassiopoulos AK, Xue L, Maddox E, Armistead D, Burgess WH, Greisler HP,. Heparin-independent mitogenicity in an endothelial and smooth muscle cell chimeric growth factor (S130K-HBGAM). Am J Surg 2004; 188: 575-579.